EPYSQLI vs FABHALTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. EPYSQLI and FABHALTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EPYSQLI	FABHALTA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ECULIZUMAB-AAGH	IPTACOPAN HYDROCHLORIDE
Manufacturer	Samsung Bioepis Co Ltd	Novartis
Dosage forms	Injectable	Capsule
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Paroxysmal Hemoglobinuria, Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome	Paroxysmal Hemoglobinuria

epysqli fabhalta

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

ECULIZUMAB-AAGH

IPTACOPAN HYDROCHLORIDE

Manufacturer

Samsung Bioepis Co Ltd

Novartis

Dosage forms

Injectable

Capsule

Drug class

—

Boxed warning

Treats

Paroxysmal Hemoglobinuria, Myasthenia Gravis, Atypical Hemolytic Uremic Syndrome

Paroxysmal Hemoglobinuria

Frequently asked questions

What is the difference between Epysqli and Fabhalta?

Epysqli contains Eculizumab-Aagh, while Fabhalta contains Iptacopan Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.